跳至主要内容
临床试验/DRKS00028081
DRKS00028081已完成4 期

Prospective, randomized, controlled,multi-centre study on secondary prevention ofchronic ischemicheart disease through a digital program - CHANGE

Vantis GmbH0 个研究点目标入组 180 人开始时间: 2022年6月14日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
180

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • (i) Patients aged 18 years and older with
  • chronic ischemic heart disease (I25 according to ICD-10)
  • (ii) Patient understands patient information
  • and agrees to participate in the study

排除标准

  • (i) No compatible smartphone available or unable to operate it;
  • (ii) Insufficient understanding of the languages offered in VT (currently only German)
  • (iii) Start of participation in another clinical study after inclusion in the present study
  • (iv) Participation in an ischemic heart disease related rehabilitation measure is planned or
  • less than 2 months ago
  • (v) Dependency or employment relationship to the sponsor or investigator

研究者

发起方
Vantis GmbH

相似试验